Type 1 (Sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration

Retina

Volumn 32, Issue 9, 2012, Pages 1829-1837

  Fung, Adrian T ^a   Yannuzzi, Lawrence A ^a,b,c   Bailey Freund, K ^a,b,c  

^a EAR AND THROAT HOSPITAL   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c New York Presbyterian Hospital   (United States)

Author keywords

age related macular degeneration; central serous chorioretinopathy; pigment epithelial detachment; polypoidal choroidal vasculopathy; Type 1 neovascularization

Indexed keywords

VISUAL PIGMENT;

ADULT; AGED; ARTICLE; AUTOFLUORESCENCE; CHORIORETINOPATHY; CHRONIC DISEASE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; IMAGING; INFRARED PHOTOGRAPHY; MALE; MEDICAL RECORD REVIEW; NEOVASCULARIZATION (PATHOLOGY); OPTICAL COHERENCE TOMOGRAPHY; PREVALENCE; RETINA MACULA DEGENERATION; RETINA PIGMENT EPITHELIOPATHY; RETROSPECTIVE STUDY;

AGED; CENTRAL SEROUS CHORIORETINOPATHY; COLORING AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; MALE; MIDDLE AGED; RETINAL NEOVASCULARIZATION; RETINAL PIGMENT EPITHELIUM; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; WET MACULAR DEGENERATION;

EID: 84866944123     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182680a66     Document Type: Article

References (46)

1. Freund KB, Zweifel SA, Engelbert M. Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina 2010;30:1333-1349.
2. Yannuzzi LA. Central serous chorioretinopathy: a personal perspective. Am J Ophthalmol 2010;149:361-363.
3. Loo RH, Scott IU, Flynn HW Jr, et al. Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina 2002; 22:19-24.
4. Spaide RF, Campeas L, Haas A, et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology 1996; 103:2070-2090; discussion 9-80.
5. Konstantinidis L, Mantel I, Zografos L, Ambresin A. Intravitreal ranibizumab in the treatment of choroidal neovascularization associated with idiopathic central serous chorioretinopathy. Eur J Ophthalmol 2010;20:955-958.
6. Chan W-M, Lai TYY, Liu DTL, Lam DSC. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 2007; 143:977-983.
7. Canakis C, Conway MD, Livir-Rallatos C, et al. Ocular photodynamic therapy in choroidal neovascularization complicating idiopathic central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging 2004;35:168-171.
8. Chan WM, Lam DSC, Lai TYY, et al. Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin. Am J Ophthalmol 2003; 136:836-845.
9. Ergun E, Tittl M, SturM. Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy. Arch Ophthalmol 2004;122:37-41.
10. Maia HS, Turchetti R, Zajdenweber M, Brasil OFM. [Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in central serous chorioretinopathy: case report]. [Article in Portuguese] Arquivos Brasileiros de Oftalmologia 2005;68:561-564.
11. Yang C-S, Chen K-C, Lee S-M, Lee F-L. Photodynamic therapy in the treatment of choroidal neovascularization complicating central serous chorioretinopathy. J Chin Med Assoc 2009;72:501-505.
12. Cooper BA, Thomas MA. Submacular surgery to remove choroidal neovascularization associated with central serous chorioretinopathy. Am J Ophthalmol 2000;130:187-191.
13. Mudvari SS, Goff MJ, Fu AD, et al. The natural history of pigment epithelial detachment associated with central serous chorioretinopathy. Retina 2007;27:1168-1173.
14. Schatz H, Madeira D, Johnson RN, McDonald HR. Central serous chorioretinopathy occurring in patients 60 years of age and older. Ophthalmology 1992;99:63-67.
15. Lafaut BA, Salati C, Priem H, De Laey JJ. Indocyanine green angiography is of value for the diagnosis of chronic central serous chorioretinopathy in elderly patients. Graefes Arch Clin Exp Ophthalmol 1998;236:513-521.
16. Khan S, Engelbert M, Imamura Y, Freund KB. Polypoidal choroidal vasculopathy: simultaneous indocyanine green angiography and eye-tracked spectral domain optical coherence tomography findings. Retina 2012;32:1057-1068.
17. Age-Related Eye Disease Study Research Group. The Age- Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol 2001;132:668-681.
18. Iida T, Yannuzzi LA, Spaide RF, et al. Cystoid macular degeneration in chronic central serous chorioretinopathy. Retina 2003;23:1-7; quiz 137-138.
19. Schatz H, Osterloh MD, McDonald HR, Johnson RN. Development of retinal vascular leakage and cystoid macular oedema secondary to central serous chorioretinopathy. Br J Ophthalmol 1993;77:744-746.
20. Cho M, Athanikar A, Paccione J, Wald KJ. Optical coherence tomography features of acute central serous chorioretinopathy versus neovascular age-related macular degeneration. Br J Ophthalmol 2010;94:597-599.
21. Imamura Y, Fujiwara T, Spaide RF. Fundus autofluorescence and visual acuity in central serous chorioretinopathy. Ophthalmology 2011;118:700-705.
22. Spaide RF, Hall L, Haas A, et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 1996;16:203-213.
23. Lumbroso B, Savastano MC, Rispoli M, et al. Morphologic differences, according to etiology, in pigment epithelial detachments by means of en face optical coherence tomography. Retina 2011;31:553-558.
24. Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 2009;29:1469-1473.
25. Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol 2009;147:811-815.
26. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004; 137:486-495.
27. Berger AR, Olk RJ, Burgess D. Central serous choroidopathy in patients over 50 years of age. Ophthalmic Surg 1991;22: 583-590.
28. Seddon JM, Chen CA. The epidemiology of age-related macular degeneration. Int Ophthalmol Clin 2004;44:17-39.
29. Zayit-Soudry S, Moroz I, Loewenstein A. Retinal pigment epithelial detachment. Surv Ophthalmol 2007;52:227-243.
30. Casswell AG, Kohen D, Bird AC. Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol 1985;69:397-403.
31. Green WR, McDonnell PJ, Yeo JH. Pathologic features of senile macular degeneration. Ophthalmology 1985;92:615-627.
32. Marshall GE, Konstas AG, Reid GG, et al. Collagens in the aged human macula. Graefes Arch Clin Exp Ophthalmol 1994; 232:133-140.
33. Imamura Y, Engelbert M, Iida T, et al. Polypoidal choroidal vasculopathy: a review. Surv Ophthalmol 2010;55:501-515.
34. Ueta T, Obata R, Inoue Y, et al. Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology 2009; 116:2400-2406.
35. Ahuja RM, Downes SM, Stanga PE, et al. Polypoidal choroidal vasculopathy and central serous chorioretinopathy. Ophthalmology 2001;108:1009-1010.
36. Koh A, Ahuja R, Downes S, Bird A. Polypoidal choroidal vasculopathy in patients with chronic central serous chorioretinopathy. Invest Ophthalmol Vis Sci 1999;40:5958.
37. Chung SE, Kang SW, Lee JH, Kim YT. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology 2011;118:840-845.
38. Sho K, Takahashi K, Yamada H, et al. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol 2003;121:1392-1396.
39. Maruko I, Iida T, Saito M, et al. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 2007;144:15-22.
40. Lafaut BA, Aisenbrey S, Van den Broecke C, et al. Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina 2000;20: 650-654.
41. Rosa RH Jr, Davis JL, Eifrig CWG. Clinicopathologic reports, case reports, and small case series: clinicopathologic correlation of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 2002;120:502-508.
42. Terasaki H, Miyake Y, Suzuki T, et al. Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation. Br J Ophthalmol 2002;86:321-327.
43. Sasahara M, Tsujikawa A, Musashi K, et al. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. Am J Ophthalmol 2006;142:601-607.
44. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431.
45. Tong J-P, Chan W-M, Liu DTL, et al. Aqueous humor levels of vascular endothelial growth factor and pigment epitheliumderived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol 2006;141:456-462.
46. Yannuzzi LA, Slakter JS, Gross NE, et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 2003;23:288-298.